DEE Development Engineers Corrects ESOP Share Allotment, Issues 1,20,784 Equity Shares Raising Paid-up Capital
Post-allotment paid-up share capital increased to Rs. 75,36,02,220 after issuing shares at Rs. 10 exercise price on 6 November 2026
DEE Development Engineers Limited issued 1,20,784 equity shares at Rs. 10 each under its Employee Stock Option Scheme on November 6, 2026, correcting earlier disclosure of 1,19,824 shares. The post-allotment paid-up share capital increased to Rs. 75,36,02,220 comprising 7,53,60,222 shares. The equity shares rank pari-passu with existing shares, and total money realized from the exercise was Rs. 12,07,840.
DEE Development Engineers Limited
Preferential Issue
DEE Development Engineers Limited issued 1,20,784 equity shares under its Employee Stock Option Scheme on 6 November 2026, correcting a previously disclosed lower figure. This allotment raised the company's paid-up capital to Rs. 75,36,02,220, with the shares carrying a face value of Rs. 10 each.
The company identified a typographical error in an earlier disclosure dated 6 November 2026 where the number of shares allotted was mistakenly reported as 1,19,824 instead of the correct figure of 1,20,784.
The shares allotted arose from employees exercising stock options under the DEE Employee Stock Option Scheme, 2023, with an exercise price of Rs. 10 per share.
The total money realized from this allotment was Rs. 12,07,840 excluding taxes.
Post allotment, the total equity shares increased to 7,53,60,222 shares, reflecting a paid-up capital of Rs. 75,36,02,220, up from Rs. 75,23,94,380 prior to the allotment.
The newly allotted shares rank pari-passu with all existing shares of the company, maintaining identical rights and privileges.
Highlights
- Corrected equity shares allotted: 1,20,784 shares with face value Rs. 10 each
- Exercise price per share: Rs. 10
- Money realized from option exercise: Rs. 12,07,840 (excluding tax)
- Post allotment total paid-up capital: Rs. 75,36,02,220
- Shares rank pari-passu with existing equity shares
- Allotment date: 6 November 2026 under 'DEE Employee Stock Option Scheme, 2023'
Key Data Snapshot
What happened
- DEE Development Engineers corrected its earlier disclosure regarding equity shares issued under its Employee Stock Option Scheme on 6 November 2026.
- The correct number of shares allotted is 1,20,784 equity shares instead of previously stated 1,19,824 shares.
- Shares were allotted at an exercise price of Rs. 10 per share to eligible employees under the DEE Employee Stock Option Scheme, 2023.
Key details
- The total money realized by the company from the exercise of options is Rs. 12,07,840 excluding taxes.
- Post allotment, the company’s paid-up share capital increased to Rs. 75,36,02,220 from Rs. 75,23,94,380.
- The allotted shares rank pari-passu with all existing equity shares.
- The allotment involved 95 eligible employees as allottees.
Regulatory and governance context
- This correction was submitted as a corrigendum to the intimation dated 6 November 2026 under SEBI Listing Regulations.
- The disclosure complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The stock option scheme is in line with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Highlights
- Corrected equity shares allotted: 1,20,784 shares with face value Rs. 10 each
- Exercise price per share: Rs. 10
- Money realized from option exercise: Rs. 12,07,840 (excluding tax)
- Post allotment total paid-up capital: Rs. 75,36,02,220
- Shares rank pari-passu with existing equity shares
- Allotment date: 6 November 2026 under 'DEE Employee Stock Option Scheme, 2023'
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
More News on Preferential Issue
View allLatest corporate announcements and market updates in Preferential Issue.
Jubilant Pharmova Receives Shareholder Approval for Private Placement of Non-Convertible Debentures
Jubilant Pharmova Limited has obtained shareholder approval through a postal ballot conducted on November 20, 2026, for the issuance of Non-Convertible Debentures on a private placement basis, allowing the company to raise debt capital.
Read Full StoryIndian Bank Approves Rs. 3000 Crore Additional Capital Raise via Basel III AT1/Tier 2 Bonds for FY 2026-27
Indian Bank's Board of Directors approved raising an additional Rs. 3000 crore through Basel III compliant Additional Tier 1 (AT1) or Tier 2 Bonds, increasing its total capital raising approval to Rs. 5000 crore for the financial year 2026-27.
Read Full StoryZelio E-Mobility Approved by BSE for Rs. 16.5 Crore Preferential Equity and Convertible Warrant Issue
Zelio E-Mobility Limited has obtained in-principle approval from BSE to issue 9,73,000 equity shares and 9,96,000 convertible warrants in a preferential allotment at a price of Rs. 853 per share or warrant, targeting both non-promoter and promoter investors.
Read Full Story